Literature DB >> 21371595

Protein thermal shifts to identify low molecular weight fragments.

James K Kranz1, Celine Schalk-Hihi.   

Abstract

Measuring the strength of binding of low molecular weight ligands to a target protein is a significant challenge to fragment-based drug discovery that must be solved. Thermal shift assays are uniquely suited for this purpose, due to the thermodynamic effects of a ligand on protein thermal stability. We show here how to implement a thermal shift assay, describing the basic features and analysis of the protein unfolding data. We then describe in detail the effects of a ligand on the observed stability of the protein to produce a shift in stability. The anatomy of ligand-induced thermal shift data is discussed in detail. We describe the unique aspects of concentration-response curves, the effect of protein unfolding energetics, and the stoichiometry of the interaction. We outline a typical assay development strategy for optimizing dye type and concentration, protein concentration, and buffer conditions. Guidelines are presented to demonstrate the limits of detection for weak-binding ligands, as applied to sulfonamide-based inhibitors of carbonic anhydrase II and applied to nucleotide binding to the death-associated protein kinase 1 catalytic domain.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371595     DOI: 10.1016/B978-0-12-381274-2.00011-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  34 in total

1.  A three-stage biophysical screening cascade for fragment-based drug discovery.

Authors:  Ellene H Mashalidis; Paweł Śledź; Steffen Lang; Chris Abell
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

2.  Analysis of protein stability and ligand interactions by thermal shift assay.

Authors:  Kathy Huynh; Carrie L Partch
Journal:  Curr Protoc Protein Sci       Date:  2015-02-02

Review 3.  Evolutions in fragment-based drug design: the deconstruction-reconstruction approach.

Authors:  Haijun Chen; Xiaobin Zhou; Ailan Wang; Yunquan Zheng; Yu Gao; Jia Zhou
Journal:  Drug Discov Today       Date:  2014-09-27       Impact factor: 7.851

4.  Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening.

Authors:  Mária Szaszkó; István Hajdú; Beáta Flachner; Krisztina Dobi; Csaba Magyar; István Simon; Zsolt Lőrincz; Zoltán Kapui; Tamás Pázmány; Sándor Cseh; György Dormán
Journal:  Mol Divers       Date:  2017-01-09       Impact factor: 2.943

5.  Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Erik Chorell; Jan M Crowley; Corinne K Cusumano; Scott Campbell; Jeffrey P Henderson; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2012-04-13       Impact factor: 7.446

Review 6.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

7.  Volume of Hsp90 ligand binding and the unfolding phase diagram as a function of pressure and temperature.

Authors:  Vytautas Petrauskas; Joana Gylytė; Zigmantas Toleikis; Piotras Cimmperman; Daumantas Matulis
Journal:  Eur Biophys J       Date:  2013-01-05       Impact factor: 1.733

8.  The collagen-like protein gp12 is a temperature-dependent reversible binder of SPP1 viral capsids.

Authors:  Mohamed Zairi; Asita C Stiege; Naima Nhiri; Eric Jacquet; Paulo Tavares
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

9.  Discovery and Optimization of Inhibitors of the Parkinson's Disease Associated Protein DJ-1.

Authors:  Shinya Tashiro; Jose M M Caaveiro; Makoto Nakakido; Aki Tanabe; Satoru Nagatoishi; Yasushi Tamura; Noriyuki Matsuda; Dali Liu; Quyen Q Hoang; Kouhei Tsumoto
Journal:  ACS Chem Biol       Date:  2018-08-15       Impact factor: 5.100

10.  NMR-based fragment screening and lead discovery accelerated by principal component analysis.

Authors:  Andrew T Namanja; Jia Xu; Haihong Wu; Qi Sun; Anup K Upadhyay; Chaohong Sun; Steven R Van Doren; Andrew M Petros
Journal:  J Biomol NMR       Date:  2019-09-20       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.